Use Designs for Health OmegAvail (Synergy, Hi-Po, TG1000) to nutritionally support cardiovascular health and healthy lipid levels by selecting the EPA/DHA dose to the patient's lipid context — Synergy for daily foundational support, Hi-Po for aggressive concentration, TG1000 for triglyceride-form delivery. SupplementPractice.com codifies these into a Cardiovascular Foundation Master Protocol.
OmegAvail Variants and Use
| SKU | EPA + DHA | Best Use |
|---|---|---|
| OmegAvail Synergy | ~600 mg combined | Daily foundation |
| OmegAvail Hi-Po | ~1,000 mg | Aggressive lipid context |
| OmegAvail TG1000 | Triglyceride form | Higher absorption |
| OmegAvail Liquid | Pediatric / dose-flexible | Children · pill aversion |
Picking the Right OmegAvail Per Patient
Patients with strong baseline diet and steady cardiovascular markers do well on OmegAvail Synergy. Patients on aggressive lipid-management programs benefit from OmegAvail Hi-Po. TG1000's triglyceride form earns its place when absorption is the limiting factor.
How SupplementPractice.com Routes the Right Variant
The AI Clinical Co-Pilot reads the patient's intake survey and lipid context, suggests the matching OmegAvail variant, generates the printable schedule, and fires the Stripe / Square recurring charge — all from inside the patient chart.
